140 related articles for article (PubMed ID: 2538970)
21. Interaction of nicotine with anticancer treatment.
Berger MR; Zeller WJ
Klin Wochenschr; 1988; 66 Suppl 11():127-33. PubMed ID: 3184771
[TBL] [Abstract][Full Text] [Related]
22. Morphology of transplanted tumours and drug induced regression in the subrenal capsule assay (SRCA) of mice and rats.
Stenbäck F; Wasenius VM; Kangas L
Ann Chir Gynaecol Suppl; 1985; 199():31-7. PubMed ID: 3904585
[TBL] [Abstract][Full Text] [Related]
23. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
[TBL] [Abstract][Full Text] [Related]
24. MXT mammary tumor treated by low dose chemotherapy. A 31P-NMR and 1H-MRI study.
Scheiber C; Kiss R; De Launoit Y; Frühling J
Anticancer Res; 1988; 8(3):403-7. PubMed ID: 2839100
[TBL] [Abstract][Full Text] [Related]
25. Transformation in vitro of a nontumorigenic rat urothelial cell line by hydrogen peroxide.
Okamoto M; Kawai K; Reznikoff CA; Oyasu R
Cancer Res; 1996 Oct; 56(20):4649-53. PubMed ID: 8840979
[TBL] [Abstract][Full Text] [Related]
26. Characterization of a preclinical model of simultaneous breast and ovarian cancer progression.
Ting AY; Kimler BF; Fabian CJ; Petroff BK
Carcinogenesis; 2007 Jan; 28(1):130-5. PubMed ID: 16891317
[TBL] [Abstract][Full Text] [Related]
27. Development of more selective anti-cancer nitrosoureas.
Eisenbrand G; Berger MR; Fischer J; Schneider MR; Tang W; Zeller WJ
Anticancer Drug Des; 1988 Mar; 2(4):351-9. PubMed ID: 3365304
[TBL] [Abstract][Full Text] [Related]
28. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
[TBL] [Abstract][Full Text] [Related]
29. Tranilast inhibits the growth and metastasis of mammary carcinoma.
Chakrabarti R; Subramaniam V; Abdalla S; Jothy S; Prud'homme GJ
Anticancer Drugs; 2009 Jun; 20(5):334-45. PubMed ID: 19322072
[TBL] [Abstract][Full Text] [Related]
30. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
[TBL] [Abstract][Full Text] [Related]
31. Coexistence of different tissue tumourigenesis in an N-methyl-N-nitrosourea-induced mammary carcinoma model: a histopathological report in Sprague-Dawley rats.
Esendagli G; Yilmaz G; Canpinar H; Gunel-Ozcan A; Guc MO; Guc D
Lab Anim; 2009 Jan; 43(1):60-4. PubMed ID: 18987061
[TBL] [Abstract][Full Text] [Related]
32. [In vitro culture of clonogenic cells from various human tumors: chemosensitivity tests].
Bénard J; Riou G
Bull Cancer; 1984; 71(4):287-91. PubMed ID: 6093913
[TBL] [Abstract][Full Text] [Related]
33. Mechanism of growth inhibition of mammary carcinomas by glucarate and the glucarate: retinoid combination.
Webb TE; Abou-Issa H; Stromberg PC; Curley RC; Nguyen MH
Anticancer Res; 1993; 13(6A):2095-9. PubMed ID: 8297119
[TBL] [Abstract][Full Text] [Related]
34. Activity of mitozolomide (NSC 353451), a new imidazotetrazine, against xenografts from human melanomas, sarcomas, and lung and colon carcinomas.
Fodstad O; Aamdal S; Pihl A; Boyd MR
Cancer Res; 1985 Apr; 45(4):1778-86. PubMed ID: 3978640
[TBL] [Abstract][Full Text] [Related]
35. New estradiol-linked nitrosoureas: can the pharmacokinetic properties help to explain the pharmacodynamic activities?
Betsch B; Berger MR; Spiegelhalder B; Eisenbrand G; Schmähl D
Eur J Cancer Clin Oncol; 1989 Jan; 25(1):105-11. PubMed ID: 2920758
[TBL] [Abstract][Full Text] [Related]
36. N-methyl-N-nitrosourea-induced mammary carcinogenesis is promoted by short-term treatment with estrogen and progesterone mimicking pregnancy in aged female Lewis rats.
Tsukamoto R; Mikami T; Miki K; Uehara N; Yuri T; Matsuoka Y; Okazaki K; Tsubura A
Oncol Rep; 2007 Aug; 18(2):337-42. PubMed ID: 17611653
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of new estrogen-linked 2-chloroethylnitrosoureas. I. Short term anticancer efficacy in methylnitrosourea-induced rat mammary carcinoma and hormonal activity in mice.
Berger MR; Floride J; Schreiber J; Schmähl D; Eisenbrand G
J Cancer Res Clin Oncol; 1984; 108(1):148-53. PubMed ID: 6746705
[TBL] [Abstract][Full Text] [Related]
38. Mode of action of estra-1,3,5(10)-triene-3, 17 beta-diol, 3-benzoate, 17[4-[4-[bis(2-chloroethyl)amino]phenyl]-1-oxobutoxy] acetate] (KM2210) on MCF-7 human breast tumours transplanted into nude mice.
Kubota T; Ishibiki K; Abe O; Kosano H; Ohsawa N; Hoffman RM
Anticancer Res; 1993; 13(4):935-40. PubMed ID: 8352562
[TBL] [Abstract][Full Text] [Related]
39. Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.
Tong AW; Papayoti MH; Netto G; Armstrong DT; Ordonez G; Lawson JM; Stone MJ
Clin Cancer Res; 2001 Mar; 7(3):691-703. PubMed ID: 11297266
[TBL] [Abstract][Full Text] [Related]
40. Effects of different durations of estrogen and progesterone treatment on development of N-methyl-N-nitrosourea-induced mammary carcinomas in female Lewis rats.
Yuri T; Tsukamoto R; Uehara N; Matsuoka Y; Tsubura A
In Vivo; 2006; 20(6B):829-36. PubMed ID: 17203775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
